Company Overview of Lipella Pharmaceuticals, Inc.
Lipella Pharmaceuticals, Inc., a development-stage biotechnology company, focuses on the development and commercialization of topical liposomal formulations for interstitial cystitis, hemorrhagic cystitis, and overactive bladder therapeutic applications. The company is engaged in developing novel products, which focus on trans-mucosal therapy by delivering local treatments directly to their site of action. It focuses on various therapeutic areas, such as urology, including interstitial cystitis, overactive bladder, hemorrhagic cystitis, and bladder cancer; gastroenterology, including eosinophilic esophagitis; ear, nose, and throat, including chronic rhinitis; and dermatology. The company was...
400 North Lexington Avenue LL103
Pittsburgh, PA 15208
Founded in 2005
Key Executives for Lipella Pharmaceuticals, Inc.
Co-Founder, Chairman of The Board, Chief Executive Officer and President
Chief Medical Officer, Executive Vice President and Director
Compensation as of Fiscal Year 2015.
Lipella Pharmaceuticals, Inc. Key Developments
Lipella Pharmaceuticals, Inc. Presents at BIO International Convention 2015, Jun-16-2015 10:45 AM
Jun 11 15
Lipella Pharmaceuticals, Inc. Presents at BIO International Convention 2015, Jun-16-2015 10:45 AM. Venue: Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States. Speakers: Michael B. Chancellor, Chief Medical Officer, Executive Vice President and Director.
Lipella Pharmaceuticals Inc. Names David Lucchino to Board of Directors
Sep 3 13
Lipella Pharmaceuticals, Inc. announced the appointment of David L. Lucchino, co-founder and former Chief Executive Officer of Semprus BioSciences, to the company's Board of Directors. Prior to co-founding Semprus, Mr. Lucchino was a Senior Associate at Polaris Venture Partners, a $3 billion venture capital fund based in Boston. Additionally, Mr. Lucchino co-founded and served as Managing Director of LaunchCyte. Mr. Lucchino currently serves on the board of the Massachusetts Biotechnology Council and Multiple Myeloma Research Foundation. He is a Trustee of Mt. Auburn Hospital, a Harvard Medical School facility, where he serves on the hospital's Audit/Compliance and Nomination committees. He also serves on the Audit Committee for CareGroup, the parent organization of Mt. Auburn, Beth Israel Deaconess Medical Center and The New England Baptist Hospital. He most recently completed a 3-year directorship on the board of AdvaMed, the Advanced Medical Technology Association, the national trade association representing the U.S. medical device industry.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|